TABLE 3.
Item | Baseline (n = 22) | Following Surgery (n = 22) | P Value |
---|---|---|---|
Bile salts (µmol/L) | |||
ΔPDV | 4.3 [+2.2 to +8.4]† | +6.7 [+4.2 to +11.8]† | 0.029 |
ΔLiver * | |||
0.7 vs. 0.3 | −2.5 [−5.5 to −1.2]† | −3.4 [−8.2 to −2.7]† | <0.001 |
0.9 vs. 0.1 | −3.5 [−7.3 to −1.9]† | −4.7 [−10.5 to −3.6]† | <0.001 |
FGF19 (ng/mL) | |||
ΔPDV | +0.02 [+0.01 to +0.03]† | +0.02 [0.00 to +0.03]‡ | 0.633 |
ΔLiver * | |||
0.7 vs. 0.3 | 0.00 [−0.01 to +0.03] | +0.01 [−0.01 to +0.01] | 0.824 |
0.9 vs. 0.1 | −0.00 [−0.01 to +0.02] | +0.01 [−0.02 to +0.01] | 0.799 |
Data are expressed as median [IQR]. Positive ΔVA indicates release by the organ/area, and a negative ΔVA indicates uptake. P values in bold are less than 0.05 and represent significant statistical differences.
ΔVA across the liver is calculated assuming different ratios (portal vs. arterial) of blood supply to the liver. Symbols indicate significance against theoretical zero.
P < 0.001 in comparison of VA differences before and after liver resection.
P < 0.01 in comparison of VA differences before and after liver resection.